FIELD : medicine; pharmaceuticals.SUBSTANCE : group of inventions relates to the pharmaceutical industry and is a high potency pharmaceutical composition containing a reduced dosage form of particles, including highly active pancreatin, wherein said pancreatin has a specific lipase activity of at least 120?USP (US Pharmacopeia) IU/mg and is present in a dose of 100–110?mg of active pharmaceutical ingredient (API) per dosage amount. Invention also includes a method for producing highly active pancreatin and a method for treating a patient exposed to a physiological condition associated with a deficiency of pancreatic enzymes, through the use of said high potency pharmaceutical composition.EFFECT : group of inventions allows to obtain pancreatin with lipase activity of at least 120?IU/mg, for which the dose is 100–110 mg per dosage form, which allows to reduce the biological load.42 cl, 21 tbl, 9 ex